The artificial intelligence (ai)-enhanced medication adherence sensor market size has grown rapidly in recent years. It will grow from $1.96 billion in 2025 to $2.34 billion in 2026 at a compound annual growth rate (CAGR) of 19.7%. The growth in the historic period can be attributed to medication non-adherence issues, chronic disease growth, digital health adoption, clinical trial monitoring needs, wearable sensor innovation.
The artificial intelligence (ai)-enhanced medication adherence sensor market size is expected to see rapid growth in the next few years. It will grow to $4.75 billion in 2030 at a compound annual growth rate (CAGR) of 19.4%. The growth in the forecast period can be attributed to remote patient monitoring growth, ai-driven adherence analytics, value-based care models, elderly population expansion, pharma trial digitization. Major trends in the forecast period include real-time medication monitoring, chronic disease compliance tools, remote patient monitoring, elderly medication management, clinical trial adherence tracking.
The rising demand for remote patient monitoring is expected to drive the growth of the artificial intelligence (AI)-enhanced medication adherence sensor market going forward. Remote patient monitoring (RPM) uses connected digital technologies to collect and transmit patients’ health data from outside traditional healthcare settings, enabling clinicians to monitor and manage conditions in real time. The expansion of RPM is being fueled by increased investments in digital health infrastructure, accelerating the integration of connected monitoring technologies into patient care. AI-enhanced medication adherence sensors track medication intake in real time and transmit adherence data to healthcare providers, allowing timely interventions, reducing missed doses, and enabling clinicians to monitor treatment compliance remotely. For instance, in April 2025, according to the Parliamentary Office of Science and Technology, England had 12,825 virtual ward beds in March 2025, equivalent to 20 beds per 100,000 GP-registered individuals, with 76.2% occupancy accommodating 9,767 patients. Therefore, the growing demand for remote patient monitoring is driving the artificial intelligence (AI)-enhanced medication adherence sensor market.
Major companies in the artificial intelligence (AI)-enhanced medication adherence sensor market are focusing on developing easy-to-integrate solutions such as smart pill bottle-based systems to streamline patient monitoring, enhance medication compliance, and facilitate seamless data sharing with healthcare providers. Smart pill bottle-based systems track medication intake in real time, record adherence data, and send alerts and reminders to ensure timely dosing while providing actionable insights to clinicians. For instance, in June 2024, PatchRx, a US-based digital health company, launched PatchRx Connect, an easy-to-integrate solution that embeds real-time medication adherence data directly into existing care management platforms. It enables clinical teams to gain immediate insights into patients' medication-taking behaviors without disrupting workflows or patient experience. The system includes a smart pill bottle cap (PatchCap) that tracks medication use, a cellular gateway that streams data securely without Wi-Fi or mobile app dependency, and a Connect API that allows providers to view adherence metrics within their own software, improving treatment outcomes and reducing costs through timely interventions.
In August 2025, Custom Health, a US-based provider of medication management and connected care services, acquired PatchRx for an undisclosed amount. Through this acquisition, Custom Health gains access to PatchRx’s smart pill-bottle cap technology and adherence analytics platform, enhancing its medication tracking and intervention capabilities while expanding remote monitoring of patient adherence. PatchRx is a US-based provider of artificial intelligence (AI)-enhanced medication adherence sensors.
Major companies operating in the artificial intelligence (ai)-enhanced medication adherence sensor market are AiCure Inc., AdhereTech Inc., AARDEX Group Ltd., EtectRx Inc., Proteus Digital Health, Adherium Limited, Wisepill Technologies Proprietary Ltd., SMRxT Inc., Amiko Digital Health Limited, MedMinder Systems Inc., Spencer Health Solutions Inc., iZafe Group AB, Evalan B.V., Mango Health, DoseSmart, CarePredict, Catalia Health, Sentrian, MedAdherence, Pilloxa.
North America was the largest region in the artificial intelligence (AI)-enhanced medication adherence sensor market in 2025. The regions covered in the artificial intelligence (AI)-enhanced medication adherence sensor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI)-enhanced medication adherence sensor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported sensors, microelectronics, wireless modules, and medical grade packaging used in AI enhanced medication adherence devices, raising manufacturing and device costs. These impacts are most pronounced in ingestible sensors, smart pill bottles, and smart packaging segments, particularly in Asia-Pacific and Europe where component sourcing is highly globalized. Higher costs have affected pricing for healthcare providers and pharmaceutical companies. However, tariffs have also encouraged local electronics assembly and packaging production, supporting regional supply chains and improving long term cost stability.
The artificial intelligence (AI)-enhanced medication adherence sensor market research report is one of a series of new reports that provides artificial intelligence (AI)-enhanced medication adherence sensor market statistics, including artificial intelligence (AI)-enhanced medication adherence sensor industry global market size, regional shares, competitors with a artificial intelligence (AI)-enhanced medication adherence sensor market share, detailed artificial intelligence (AI)-enhanced medication adherence sensor market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced medication adherence sensor industry. This artificial intelligence (AI)-enhanced medication adherence sensor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial intelligence (AI)-enhanced medication adherence sensors are advanced devices that monitor patients’ medication intake in real time using intelligent algorithms. They track adherence patterns, analyze data instantly, and provide actionable insights for timely intervention. These systems improve compliance, reduce missed doses, and enhance overall treatment effectiveness. Their advanced analytics enable proactive management of medication routines, supporting better health outcomes.
The main product types of AI-enhanced medication adherence sensors include wearable sensors, ingestible sensors, smart pill bottles, smart packaging, and others. Wearable sensors are devices worn on the body that monitor medication intake and physiological responses using AI algorithms for precise adherence tracking. The sensor technologies incorporate AI algorithms, Internet of Things (IoT) integration, cloud-based solutions, mobile applications, and others, and are distributed through various online and offline channels. They are applied in areas such as chronic disease management, elderly care, clinical trials, home healthcare, and others, serving end-users including patients, healthcare providers, pharmaceutical companies, and others.
The artificial intelligence (AI)-enhanced medication adherence sensor market consists of revenues earned by entities by providing services such as real-time monitoring, adherence analysis, alerts and reminders, data reporting, actionable insights, and integration with digital health platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced medication adherence sensor market also includes sales of smart medication dispensers, connected pill organizers, sensor-embedded patches, Bluetooth-enabled monitoring devices, smart dosage caps, and digital health monitoring kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The artificial intelligence (ai)-enhanced medication adherence sensor market size is expected to see rapid growth in the next few years. It will grow to $4.75 billion in 2030 at a compound annual growth rate (CAGR) of 19.4%. The growth in the forecast period can be attributed to remote patient monitoring growth, ai-driven adherence analytics, value-based care models, elderly population expansion, pharma trial digitization. Major trends in the forecast period include real-time medication monitoring, chronic disease compliance tools, remote patient monitoring, elderly medication management, clinical trial adherence tracking.
The rising demand for remote patient monitoring is expected to drive the growth of the artificial intelligence (AI)-enhanced medication adherence sensor market going forward. Remote patient monitoring (RPM) uses connected digital technologies to collect and transmit patients’ health data from outside traditional healthcare settings, enabling clinicians to monitor and manage conditions in real time. The expansion of RPM is being fueled by increased investments in digital health infrastructure, accelerating the integration of connected monitoring technologies into patient care. AI-enhanced medication adherence sensors track medication intake in real time and transmit adherence data to healthcare providers, allowing timely interventions, reducing missed doses, and enabling clinicians to monitor treatment compliance remotely. For instance, in April 2025, according to the Parliamentary Office of Science and Technology, England had 12,825 virtual ward beds in March 2025, equivalent to 20 beds per 100,000 GP-registered individuals, with 76.2% occupancy accommodating 9,767 patients. Therefore, the growing demand for remote patient monitoring is driving the artificial intelligence (AI)-enhanced medication adherence sensor market.
Major companies in the artificial intelligence (AI)-enhanced medication adherence sensor market are focusing on developing easy-to-integrate solutions such as smart pill bottle-based systems to streamline patient monitoring, enhance medication compliance, and facilitate seamless data sharing with healthcare providers. Smart pill bottle-based systems track medication intake in real time, record adherence data, and send alerts and reminders to ensure timely dosing while providing actionable insights to clinicians. For instance, in June 2024, PatchRx, a US-based digital health company, launched PatchRx Connect, an easy-to-integrate solution that embeds real-time medication adherence data directly into existing care management platforms. It enables clinical teams to gain immediate insights into patients' medication-taking behaviors without disrupting workflows or patient experience. The system includes a smart pill bottle cap (PatchCap) that tracks medication use, a cellular gateway that streams data securely without Wi-Fi or mobile app dependency, and a Connect API that allows providers to view adherence metrics within their own software, improving treatment outcomes and reducing costs through timely interventions.
In August 2025, Custom Health, a US-based provider of medication management and connected care services, acquired PatchRx for an undisclosed amount. Through this acquisition, Custom Health gains access to PatchRx’s smart pill-bottle cap technology and adherence analytics platform, enhancing its medication tracking and intervention capabilities while expanding remote monitoring of patient adherence. PatchRx is a US-based provider of artificial intelligence (AI)-enhanced medication adherence sensors.
Major companies operating in the artificial intelligence (ai)-enhanced medication adherence sensor market are AiCure Inc., AdhereTech Inc., AARDEX Group Ltd., EtectRx Inc., Proteus Digital Health, Adherium Limited, Wisepill Technologies Proprietary Ltd., SMRxT Inc., Amiko Digital Health Limited, MedMinder Systems Inc., Spencer Health Solutions Inc., iZafe Group AB, Evalan B.V., Mango Health, DoseSmart, CarePredict, Catalia Health, Sentrian, MedAdherence, Pilloxa.
North America was the largest region in the artificial intelligence (AI)-enhanced medication adherence sensor market in 2025. The regions covered in the artificial intelligence (AI)-enhanced medication adherence sensor market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI)-enhanced medication adherence sensor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have increased the cost of imported sensors, microelectronics, wireless modules, and medical grade packaging used in AI enhanced medication adherence devices, raising manufacturing and device costs. These impacts are most pronounced in ingestible sensors, smart pill bottles, and smart packaging segments, particularly in Asia-Pacific and Europe where component sourcing is highly globalized. Higher costs have affected pricing for healthcare providers and pharmaceutical companies. However, tariffs have also encouraged local electronics assembly and packaging production, supporting regional supply chains and improving long term cost stability.
The artificial intelligence (AI)-enhanced medication adherence sensor market research report is one of a series of new reports that provides artificial intelligence (AI)-enhanced medication adherence sensor market statistics, including artificial intelligence (AI)-enhanced medication adherence sensor industry global market size, regional shares, competitors with a artificial intelligence (AI)-enhanced medication adherence sensor market share, detailed artificial intelligence (AI)-enhanced medication adherence sensor market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced medication adherence sensor industry. This artificial intelligence (AI)-enhanced medication adherence sensor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial intelligence (AI)-enhanced medication adherence sensors are advanced devices that monitor patients’ medication intake in real time using intelligent algorithms. They track adherence patterns, analyze data instantly, and provide actionable insights for timely intervention. These systems improve compliance, reduce missed doses, and enhance overall treatment effectiveness. Their advanced analytics enable proactive management of medication routines, supporting better health outcomes.
The main product types of AI-enhanced medication adherence sensors include wearable sensors, ingestible sensors, smart pill bottles, smart packaging, and others. Wearable sensors are devices worn on the body that monitor medication intake and physiological responses using AI algorithms for precise adherence tracking. The sensor technologies incorporate AI algorithms, Internet of Things (IoT) integration, cloud-based solutions, mobile applications, and others, and are distributed through various online and offline channels. They are applied in areas such as chronic disease management, elderly care, clinical trials, home healthcare, and others, serving end-users including patients, healthcare providers, pharmaceutical companies, and others.
The artificial intelligence (AI)-enhanced medication adherence sensor market consists of revenues earned by entities by providing services such as real-time monitoring, adherence analysis, alerts and reminders, data reporting, actionable insights, and integration with digital health platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced medication adherence sensor market also includes sales of smart medication dispensers, connected pill organizers, sensor-embedded patches, Bluetooth-enabled monitoring devices, smart dosage caps, and digital health monitoring kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Characteristics
3. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Supply Chain Analysis
4. Global Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Trends and Strategies
5. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Analysis of End Use Industries
7. Global Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Total Addressable Market (TAM) Analysis for the Market
9. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Segmentation
10. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Regional and Country Analysis
11. Asia-Pacific Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
12. China Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
13. India Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
14. Japan Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
15. Australia Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
16. Indonesia Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
17. South Korea Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
18. Taiwan Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
19. South East Asia Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
20. Western Europe Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
21. UK Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
22. Germany Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
23. France Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
24. Italy Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
25. Spain Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
26. Eastern Europe Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
27. Russia Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
28. North America Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
29. USA Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
30. Canada Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
31. South America Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
32. Brazil Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
33. Middle East Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
34. Africa Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market
36. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Competitive Landscape and Company Profiles
37. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market Other Major and Innovative Companies
40. Artificial Intelligence (Ai)-Enhanced Medication Adherence Sensor Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Artificial Intelligence (AI)-Enhanced Medication Adherence Sensor Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses artificial intelligence (ai)-enhanced medication adherence sensor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced medication adherence sensor? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced medication adherence sensor market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Wearable Sensors; Ingestible Sensors; Smart Pill Bottles; Smart Packaging2) By Technology: Artificial Intelligence (AI) Algorithms; Internet Of Things (IoT) Integration; Cloud-Based Solutions; Mobile Applications; Other Technologies
3) By Distribution Channel: Online; Offline
4) By Application: Chronic Disease Management; Elderly Care; Clinical Trials; Home Healthcare; Other Applications
5) By End-User: Patients; Healthcare Providers; Pharmaceutical Companies; Other End-Users
Subsegments:
1) By Wearable Sensors: Smart Wristbands; Adhesive Patches; Smartwatches; Clothing-Embedded Sensors; Arm Bands2) By Ingestible Sensors: Sensor-Embedded Pills; Biocompatible Capsules; Digestive Monitoring Sensors; pH Tracking Sensors; Temperature-Sensing Capsules
3) By Smart Pill Bottles: Bluetooth-Enabled Pill Bottles; Reminder-Integrated Bottles; Dose-Tracking Bottles; Automatic Dispensing Bottles; Sensor-Activated Bottles
4) By Smart Packaging: Blister Pack Sensors; Smart Labels; Pressure-Sensitive Packaging; Temperature-Monitoring Packaging; Tamper-Evident Smart Packs
Companies Mentioned: AiCure Inc.; AdhereTech Inc.; AARDEX Group Ltd.; EtectRx Inc.; Proteus Digital Health; Adherium Limited; Wisepill Technologies Proprietary Ltd.; SMRxT Inc.; Amiko Digital Health Limited; MedMinder Systems Inc.; Spencer Health Solutions Inc.; iZafe Group AB; Evalan B.V.; Mango Health; DoseSmart; CarePredict; Catalia Health; Sentrian; MedAdherence; Pilloxa
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this AI-Enhanced Medication Adherence Sensor market report include:- AiCure Inc.
- AdhereTech Inc.
- AARDEX Group Ltd.
- EtectRx Inc.
- Proteus Digital Health
- Adherium Limited
- Wisepill Technologies Proprietary Ltd.
- SMRxT Inc.
- Amiko Digital Health Limited
- MedMinder Systems Inc.
- Spencer Health Solutions Inc.
- iZafe Group AB
- Evalan B.V.
- Mango Health
- DoseSmart
- CarePredict
- Catalia Health
- Sentrian
- MedAdherence
- Pilloxa
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.34 Billion |
| Forecasted Market Value ( USD | $ 4.75 Billion |
| Compound Annual Growth Rate | 19.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
